Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients

BMC Cancer
Silvana Anna Maria UrruSandra Orrù

Abstract

To provide further information on the clinical and pathological prognostic factors in triple-negative breast cancer (TNBC), for which limited and inconsistent data are available. Pathological characteristics and clinical records of 841 TNBCs diagnosed between 1994 and 2015 in four major oncologic centers from Sardinia, Italy, were reviewed. Multivariate hazard ratios (HRs) for mortality and recurrence according to various clinicopathological factors were estimated using Cox proportional hazards models. After a mean follow-up of 4.3 years, 275 (33.3%) TNBC patients had a progression of the disease and 170 (20.2%) died. After allowance for study center, age at diagnosis, and various clinicopathological factors, all components of the TNM staging system were identified as significant independent prognostic factors for TNBC mortality. The HRs were 3.13, 9.65, and 29.0, for stage II, III and IV, respectively, vs stage I. Necrosis and Ki-67 > 16% were also associated with increased mortality (HR: 1.61 and 1.99, respectively). Patients with tumor histotypes other than ductal invasive/lobular carcinomas had a more favorable prognosis (HR: 0.40 vs ductal invasive carcinoma). No significant associations with mortality were found for histo...Continue Reading

References

Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent Vinh-HungChristine Bouchardy
Feb 16, 2010·The Lancet Oncology·Rinat YerushalmiKaren A Gelmon
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Jun 25, 2010·Breast Cancer Research and Treatment·Jung Ah LeeUNKNOWN Korean Breast Cancer Society
Sep 2, 2010·Breast Cancer Research : BCR·Emad A RakhaIan O Ellis
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonel F Hernandez-AyaAna Maria Gonzalez-Angulo
Oct 1, 2011·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN International Ki-67 in Breast Cancer Working Group
Apr 3, 2012·Breast Cancer Research and Treatment·Elisabetta MunzoneG Viale
Mar 1, 2011·Radiology and Oncology·Tanja OvcaricekSimona Borstnar
Oct 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Boyle
Oct 27, 2012·Clinical Breast Cancer·Emilia MontagnaMarco Colleoni
Feb 19, 2013·The Breast : Official Journal of the European Society of Mastology·Geertje DreyerHans Wildiers
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Aug 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C DenkertG von Minckwitz
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Mar 18, 2015·Nature Reviews. Clinical Oncology·Fabrice AndreSuzette Delaloge
May 6, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S CoatesUNKNOWN Panel Members
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Nov 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PruneriG Viale
Oct 21, 2016·Breast Cancer Research : BCR·Mustapha AbubakarMontserrat Garcia-Closas

❮ Previous
Next ❯

Citations

Jun 12, 2018·Obstetrics and Gynecology·Kelly Kuo, Aaron B Caughey
Mar 12, 2019·Journal of X-ray Science and Technology·Zong-Qiong SunGen Yan
Sep 3, 2018·Clinical & Experimental Metastasis·Verena KirnJochen Fries
Apr 24, 2020·Proceedings of the National Academy of Sciences of the United States of America·Sanghoon LeeXiao-Song Wang
Nov 12, 2020·Cancers·Andrea AngiusMaria Rosaria De Miglio
Jan 4, 2021·Breast Cancer Research and Treatment·Mei-Yin C PolleyMatthew P Goetz
Jun 21, 2020·Pathology·Hemamali SamaratungaLars Egevad
Aug 20, 2019·Current Medicinal Chemistry·Thaise Gonçalves AraújoAdemar Alves da Silva Filho
Sep 19, 2021·NPJ Precision Oncology·Samuel Terkper AhunoUNKNOWN Ghana Breast Health Study Team
Nov 16, 2021·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Andy EvansAlastair Thompson

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.